{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:25Z","timestamp":1791994585134,"version":"4.4.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":208,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["#5u19AI056363-7"],"award-info":[{"award-number":["#5u19AI056363-7"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/bjd.13350","type":"journal-article","created":{"date-parts":[[2014,8,13]],"date-time":"2014-08-13T18:07:31Z","timestamp":1407953251000},"page":"760-768","source":"Crossref","is-referenced-by-count":41,"title":["A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone"],"prefix":"10.1093","volume":"172","author":[{"suffix":"III","given":"R.P.","family":"Hall","sequence":"first","affiliation":[{"name":"Department of Dermatology; Duke Hospital South; Duke University Medical Center; Room 4044 Durham NC 27710 U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Fairley","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Iowa; Iowa City IA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Woodley","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Southern California; Los Angeles CA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.P.","family":"Werth","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Pennsylvania; Philadelphia PA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hannah","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Duke Hospital South; Duke University Medical Center; Room 4044 Durham NC 27710 U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Streilein","sequence":"additional","affiliation":[{"name":"Department of Dermatology; Duke Hospital South; Duke University Medical Center; Room 4044 Durham NC 27710 U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"McKillip","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Iowa; Iowa City IA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Okawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Pennsylvania; Philadelphia PA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Rose","sequence":"additional","affiliation":[{"name":"Department of Dermatology; University of Pennsylvania; Philadelphia PA U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.L.","family":"Keyes-Elstein","sequence":"additional","affiliation":[{"name":"Rho, Inc.; Chapel Hill NC U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pinckney","sequence":"additional","affiliation":[{"name":"Rho, Inc.; Chapel Hill NC U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Overington","sequence":"additional","affiliation":[{"name":"Rho, Inc.; Chapel Hill NC U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wedgwood","sequence":"additional","affiliation":[{"name":"Clinical Immunology Branch; Division of Allergy, Immunology and Transplantation; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda MD U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ding","sequence":"additional","affiliation":[{"name":"Clinical Immunology Branch; Division of Allergy, Immunology and Transplantation; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda MD U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Welch","sequence":"additional","affiliation":[{"name":"Clinical Immunology Branch; Division of Allergy, Immunology and Transplantation; National Institute of Allergy and Infectious Diseases; National Institutes of Health; Bethesda MD U.S.A"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,2,5]]},"reference":[{"key":"10.1111\/bjd.13350-BIB0001|bjd13350-cit-0001","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/archdermatol.2009.205","article-title":"Mortality of bullous skin disorders from 1979 through 2002 in the United States","volume":"145","author":"Risser","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13350-BIB0002|bjd13350-cit-0002","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/bjd.13350-BIB0003|bjd13350-cit-0003","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jaad.2010.04.039","article-title":"A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus","volume":"64","author":"Martin","year":"2011","journal-title":"JAAD"},{"key":"10.1111\/bjd.13350-BIB0004|bjd13350-cit-0004","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1365-2133.2005.06672.x","article-title":"Infliximab in the management of severe pemphigus vulgaris","volume":"153","author":"Pardo","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13350-BIB0005|bjd13350-cit-0005","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2133.2005.06744.x","article-title":"Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab","volume":"153","author":"Jacobi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13350-BIB0006|bjd13350-cit-0006","first-page":"245","article-title":"Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept","volume":"74","author":"Berookhim","year":"2004","journal-title":"Cutis"},{"key":"10.1111\/bjd.13350-BIB0007|bjd13350-cit-0007","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1001\/archderm.141.6.680","article-title":"Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser","volume":"141","author":"Lin","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/bjd.13350-BIB0008|bjd13350-cit-0008","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1523-1747.2000.00835.x","article-title":"In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis","volume":"114","author":"Feliciani","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13350-BIB0009|bjd13350-cit-0009","first-page":"220","article-title":"Anti-intercellular substance antibody log titres are correlated with serum concentrations of interleukin-6, interleukin-15 and tumor necrosis factor-alpha in patients with pemphigus vulgaris relationships with peripheral blood neutrophil counts, disease severity and duration and patients\u2019 age","volume":"13","author":"Ameglio","year":"1999","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1111\/bjd.13350-BIB0010|bjd13350-cit-0010","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1034\/j.1600-0625.2002.120415.x","article-title":"Urokinase plasminogen activator mRNA is induced by IL-1alpha and TNF-alpha in in vitro acantholysis","volume":"12","author":"Feliciani","year":"2003","journal-title":"Exp Dermatol"},{"key":"10.1111\/bjd.13350-BIB0011|bjd13350-cit-0011","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jaad.2008.09.052","article-title":"A randomized double-blind trial of intravenous immunoglobulin for pemphigus","volume":"60","author":"Amagai","year":"2009","journal-title":"JAAD"},{"key":"10.1111\/bjd.13350-BIB0012|bjd13350-cit-0012","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1038\/jid.2010.91","article-title":"Treating pemphigus vulgaris with prednisone and mycophenolate mofetil: a multicenter, randomized, placebo-controlled trial","volume":"130","author":"Beissert","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13350-BIB0013|bjd13350-cit-0013","first-page":"997","article-title":"The Dermatology Life Quality Index 1994 2007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.13350-BIB0014|bjd13350-cit-0014","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1038\/jid.2009.72","article-title":"Comparison of reliability and validity between two outcome instruments for pemphigus","volume":"129","author":"Rosenbach","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1111\/bjd.13350-BIB0015|bjd13350-cit-0015","doi-asserted-by":"crossref","first-page":"e1000107","DOI":"10.1371\/journal.pmed.1000107","article-title":"Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection","volume":"6","author":"Levesque","year":"2009","journal-title":"PLoS Med"},{"key":"10.1111\/bjd.13350-BIB0016|bjd13350-cit-0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/bjd.13350-BIB0017|bjd13350-cit-0017","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10067-009-1340-7","article-title":"Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs","volume":"29","author":"Atteno","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1111\/bjd.13350-BIB0018|bjd13350-cit-0018","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1186\/ar3058","article-title":"74-week follow-up of safety of infliximab in patients with refractory rheumatoid arthritis","volume":"12","author":"Delabaye","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1111\/bjd.13350-BIB0019|bjd13350-cit-0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ibd.21697","article-title":"Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies","volume":"18","author":"Reinisch","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/bjd.13350-BIB0020|bjd13350-cit-0020","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1038\/jid.2008.178","article-title":"B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses","volume":"128","author":"Mouquet","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.13350-BIB0021|bjd13350-cit-0021","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.13350-BIB0022|bjd13350-cit-0022","doi-asserted-by":"crossref","first-page":"688","DOI":"10.4049\/jimmunol.180.2.688","article-title":"Cutting edge: anti-tumor necrosis factor therapy in rheumatoid arthritis inhibits memory B lymphocytes via effects on lymphoid germinal centers and follicular dendritic cell networks","volume":"180","author":"Anolik","year":"2008","journal-title":"J Immunol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.13350","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.13350\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:11:54Z","timestamp":1676365914000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/172\/3\/760\/6615825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.13350","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718533118.793506052","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718533118.793500413","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718533118.793500638","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.718533118.793503886","asserted-by":"object"}]},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2,5]]}}}